FGFR3 dysregulation and clinical outcome in myeloma
- PMID: 12492593
- DOI: 10.1046/j.1365-2141.2003.03983_1.x
FGFR3 dysregulation and clinical outcome in myeloma
Comment on
-
t(4;14)(p16.3;q32) is strongly associated with a shorter survival in myeloma patients.Br J Haematol. 2003 Jan;120(1):170-1. doi: 10.1046/j.1365-2141.2003.03983_5.x. Br J Haematol. 2003. PMID: 12492597 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical